Dose unique And NotWilliam G. Ondo
List of bibliographic references
Number of relevant bibliographic references: 11.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000928 | Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Cesaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France] | Orodispersible Sublingual Piribedil to Abort OFF Episodes: A Single Dose Placebo-Controlled, Randomized, Double-Blind, Cross-Over Study |
| 000D98 | A. Sebastian Schroeder [Allemagne] ; Birgit Ertl-Wagner [Allemagne] ; Stefanie Britsch [Allemagne] ; J. Michael Schroder [Allemagne] ; Stefan Nikolin [Allemagne] ; Joachim Weis [Allemagne] ; Wolfgang Müller-Felber [Allemagne] ; Inga Koerte [Allemagne] ; Maximilian Stehr [Allemagne] ; Steffen Berweck [Allemagne] ; Ingo Borggraefe [Allemagne] ; Florian Heinen [Allemagne] | Muscle Biopsy Substantiates Long-Term MRI Alterations One Year After A Single Dose of Botulinum Toxin Injected into the Lateral Gastrocnemius Muscle of Healthy Volunteers |
| 001E58 | Nicolas Simon [France] ; Joëlle Micallef [France] ; Jean-Charles Reynier [France] ; Monique Lesourd [France] ; Tatiana Witjas [France] ; André Alicherif [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] | End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients : A pharmacokinetic/pharmacodynamic, randomized, double-blind study |
| 001E89 | Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Hughes [Australie] ; Andrew Evans [Royaume-Uni] ; Alice J. Manson [Royaume-Uni] ; Marion Hoffman [Australie] ; Lesley Swinn [Royaume-Uni] ; Hilary Watt [Royaume-Uni] ; Kailash Bhatia [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease : A prospective study using single-dose challenges |
| 002318 | Tomoyuki Uchiyama [Japon] ; Ryuji Sakakibara [Japon] ; Takamichi Hattori [Japon] ; Tomonori Yamanishi [Japon] | Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon |
| 002B25 | Kevin J. Black [États-Unis] ; Jonathan W. Mink [États-Unis] | Response to levodopa challenge in Tourette syndrome |
| 002D76 | K. R. Müller-Vahl [Allemagne] ; U. Schneider [Allemagne] ; H. M. Emrich [Allemagne] | Nabilone increases choreatic movements in Huntington's disease |
| 002E66 | M. Merello [Argentine] ; J. Balej [Argentine] ; M. Delfino [Argentine] ; A. Cammarota [Argentine] ; O. Betti [Argentine] ; R. Leiguarda [Argentine] | Apomorphine induces changes in GPi spontaneous outflow in patients with Parkinson's disease |
| 003261 | G. Gomez Arevalo [Argentine] ; R. Jorge [Argentine] ; S. Garcia [Argentine] ; O. Scipioni [Argentine] ; O. Gershanik [Argentine] | Clinical and pharmacological differences in early- versus late-onset Parkinson's disease |
| 003680 | B. Johnels [Suède] ; P. E. Ingvarsson [Suède] ; B. Holmberg ; M. Matousek [Suède] ; G. Steg [Suède] | Single-dose L-dopa response in early parkinson's disease : measurements with optoelectronic recording technique |
| 003A96 | F. Grandas ; N. Quinn ; P. Critchley ; A. Rohan ; C. D. Marsden ; S. M. Stahl | Antiparkinsonian activity of a single oral dose of PHNO |
| This area was generated with Dilib version V0.6.23. |  |